A Small-Molecule Inhibitor of Bax and Bak Oligomerization Prevents Genotoxic Cell Death and Promotes Neuroprotection

Xin Niu1, Hetal Brahmbhatt2, Philipp Mergenthaler3

  • 1Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada; Department of Biochemistry and Molecular Cell Biology, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Cell Chemical Biology
|April 11, 2017
PubMed

Insights

Scientists discovered small molecules that inhibit Bax/Bak protein oligomerization, a key step in apoptosis. These inhibitors prevent mitochondrial outer membrane permeabilization (MOMP) and protect cells, offering potential treatments for degenerative diseases.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Pharmacology

Background:

  • Aberrant apoptosis contributes to acute and chronic degenerative diseases.
  • Mitochondrial outer membrane permeabilization (MOMP) is an irreversible apoptosis execution step, triggered by Bax/Bak protein oligomerization.
  • Targeting Bax/Bak oligomerization presents a therapeutic strategy for controlling apoptosis.

Purpose of the Study:

  • To discover and characterize small-molecule inhibitors of Bax/Bak oligomerization.
  • To investigate the mechanism by which these inhibitors prevent MOMP.
  • To evaluate the therapeutic potential of inhibiting Bax/Bak oligomerization in cellular models of neurodegeneration.

Main Methods:

  • High-throughput screening for small-molecule inhibitors of Bax/Bak oligomerization.
  • Biochemical assays to assess disruption of Bax dimer interfaces and higher-order oligomer formation.
  • Cell-based assays to evaluate protection against apoptotic stimuli and excitotoxicity in neuronal models.

Main Results:

  • Discovery of novel small molecules that inhibit Bax/Bak oligomerization.
  • Demonstrated that inhibitors interfere with Bax dimer interactions, preventing higher-order oligomer formation at the MOM.
  • Inhibitors prevented MOMP, allowed cells to evade apoptosis, and rescued neurons from excitotoxicity-induced death.

Conclusions:

  • Bax/Bak oligomerization is essential for MOMP.
  • Small-molecule Bax/Bak inhibitors are effective tools for studying MOMP mechanisms.
  • These inhibitors hold promise for developing new treatments for acute and chronic degenerative diseases by modulating apoptosis.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...